Skip to content

The clinical test to consider the body fat reductional effect by taking functionality egg.

The clinical test to consider the body fat reductional effect by taking functionality egg. - The clinical test to consider the body fat reductional effect by taking functionality egg.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016081
Enrollment
60
Registered
2015-01-05
Start date
2015-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Test group 1 a day of functionality egg is taken for 12 weeks. Contorol group 1 a day of normal egg is taken for 12 weeks.

Sponsors

Anti-Aging Medical Research Center,Graduate School of Life and Medical Sciences,Doshisha Univercity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The age as of the consent brief merit of the test participation is the man and the lady who are less than 65 years old more than 40 years old. 2)The person who is being a healthy person and isn't treating it with some diseases at present. 3)BMI (Kg/m2) is a person of more than 25 less than 30. 4)A chief around the abdomen is a person of more than 85 cm of man and more than 90 cm of lady. 5)The person who can apply for participation and agree with final examination participation about a document voluntarily when he had the enough explanation about the purpose of the final examination and the contents, and there was agreement ability, and understanding well. 6)A test responsibility doctor is the person who admitted participation in the final examination to be suitable.

Exclusion criteria

Exclusion criteria: 1)The person who has trouble with some chronic malady and has a medicine medical treatment at present. 2)Severe hepatopathy, kidney, heart disease, lung, digestive organ (including stomach removal), organ obstacle, diabetes and thyroid disease, additionally, the person with whom the past is infected in a severe disease. 3)A person with the fear which indicates the allergic reaction in white, yolk (egg) and iodine, also, medical supplies, additionally, the person with fear who causes allergy to severe foods in a food. 4)AST (GOT), ALT (GPT) and gamma-GT (gamma-GTP) are more than 1.5 times of person of the standard value. 5)A person of more than 2.0 times by which a fat matter related index is the standard value (in HDL-cho, person of less than 1/2). 6)Lithic acid (UA) is a person beyond 8.5mg/dl. 7)HbA1c (NGSP) is a person beyond 7.0mg/dl. 8)Person with the medical history of the disease and a present case history of hepatitis. 9)The systolic blood pressure, more than 160 mmHg or the expansion period blood pressure is more than 100 mmHg of person. 10)Person with high anemia. etc.

Design outcomes

Primary

MeasureTime frame
FatScan abdominal fat amount measurement using a CT scan photography picture.

Secondary

MeasureTime frame
The weight, the percent of body fat, BMI measurement, around the blood pressure/pulse measurement, abdomen and buttocks chief measurement, hematology-like check, blood biochemistry-like check, blood special method inspection, urine general check, urine special method inspection, questionnaire survey and questioning by a subjective diary (A defecation investigation is included.) and questioning by a doctor

Countries

Japan

Contacts

Public ContactSeigo Isozaki

Anti-Aging Bank Co.,Ltd. Clinical test support team

isozaki@antiaging-bank.com03-5577-1010

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026